FSD Pharma Signs Binding LOI to Acquire Therapix Biosciences

Cannabis Business Times
Oct 23, 2018, 10:58 am171 pts
TORONTO – October 22, 2018 – PRESS RELEASE – FSD Pharma Inc. has announced the signing of a binding letter of intent (LOI) to acquire Therapix Biosciences Ltd. effective Oct. 22, 2018. The transaction combines two highly complementary businesses and creates a medical cannabis industry innovator focused on the…

Read Article Share
Share Article
- email
- x.com
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

NJWeedman Enjoins MSO Curaleaf Lawsuit Challenging NJ-CRC 80

Florida Proposal Would Align Cannabis and Tobacco Public Smoking Rules 79

Canada’s cannabis legalization initiative: Funding, outcomes, and departmental spending 77

Hemp Needs What Alcohol Already Has: A Clear Definition (Op-Ed) 70

The Cannabis Seed Economy: How Genetics Became the Industry’s Most Valuable Asset 57

Missouri Officials Propose Tightening Cannabis Licensing Rules 47

Ascend Q3 Revenue Drops 12% 12

Joint Wars competition to kick off MJBizCon 10

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.